Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Warfarin pharmacogenomics: recommendations with available patented clinical technologies.

Recent patents on biotechnology - 1 Jan 2014

Borkowski Andrew A, Kardani Avni, Mastorides Stephen M, Thomas L Brannon

Abstract excerpt

Warfarin pharmacogenomic testing has become a prime example of the utility of personalized molecular testing in the modern clinical laboratory. Warfarin is a commonly used drug for the prevention and treatment of thromboembolic complications in a variety of clinical situations. However, a number...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemorrhage
Share to Anticoagulants
Share to Cytochrome P-450 CYP2C9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Patents as Topic

Share to Pharmacogenetics

Share to Thromboembolism

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 25185986
DOI: 10.2174/1872208309666140904112003

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Prepared record publication-25185986-2026-09-05.1. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Warfarin pharmacogenomics: recommendations with available patented clinical technologies.PMID 25185986Read ↗

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing.Semantic proximity Read ↗

A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity.Semantic proximity Read ↗

Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.Semantic proximity Read ↗

Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.Semantic proximity Read ↗

Role of Warfarin Pharmacogenetic Testing in Clinical PracticeSemantic proximity Read ↗

Warfarin PharmacogeneticsSemantic proximity Read ↗

Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.Semantic proximity Read ↗

Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.Semantic proximity Read ↗

Should we be applying warfarin pharmacogenetics to clinical practice? No, not now.Semantic proximity Read ↗

Pharmacogenetics of warfarin: current status and future challenges.Semantic proximity Read ↗

Pharmacogenetics of warfarin: challenges and opportunitiesSemantic proximity Read ↗

Warfarin pharmacogenetics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.